Novartis
NVS
$89.42
Share price
0.87%
Change (1 day)
1.68%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Market capitalization of Novartis (NVS)
Market cap: $197.85 Billion
As of May 2022 Novartis has a market cap of $197.85 Billion. This makes Novartis the world's 46th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Novartis from 2001 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $197.85 B | 0.7% |
| 2021 | $196.46 B | -9.78% |
| 2020 | $217.77 B | 1.37% |
| 2019 | $214.83 B | 8.9% |
| 2018 | $197.28 B | 0.05% |
| 2017 | $197.18 B | 13.99% |
| 2016 | $172.98 B | -17.02% |
| 2015 | $208.46 B | -6.94% |
| 2014 | $224.01 B | 15.09% |
| 2013 | $194.64 B | 27.77% |
| 2012 | $152.33 B | 10.31% |
| 2011 | $138.09 B | 2.61% |
| 2010 | $134.58 B | 7.64% |
| 2009 | $125.03 B | 10.95% |
| 2008 | $112.69 B | -8.36% |
| 2007 | $122.98 B | -8.82% |
| 2006 | $134.88 B | 10.03% |
| 2005 | $122.58 B | -0.05% |
| 2004 | $122.65 B | 8.31% |
| 2003 | $113.24 B | 24.58% |
| 2002 | $90.90 B | -2.26% |
| 2001 | $93.00 B |
End of Day market cap according to different sources
On May 20th, 2022 the market cap of Novartis was reported to be:
$197.85 Billion
$197.85 Billion
$197.85 Billion
$217.68 Billion
$210.51 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $465.70 B | 135.38% | 🇺🇸 USA |
 Pfizer PFE | $294.40 B | 48.80% | 🇺🇸 USA |
 Abbott Laboratories ABT | $198.27 B | 0.22% | 🇺🇸 USA |
 Sanofi SNY | $135.85 B | -31.33% | 🇫🇷 France |
 Merck MRK | $236.57 B | 19.57% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $162.21 B | -18.01% | 🇺🇸 USA |
 Astrazeneca AZN | $205.18 B | 3.70% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $114.83 B | -41.96% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $9.40 B | -95.25% | 🇮🇱 Israel |